Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MS4A6A |
| Upstream (Parents) |
|---|
| (<<) GIMAP6 → MS4A6A |
| (<<) EVI2B///EVI2A → MS4A6A |
| (<<) GIMAP1 → MS4A6A |
| Downstream (Children) |
|---|
| MS4A6A → NDRG4 (>>) |
| MS4A6A → CLEC12B///CLEC12A (>>) |
| MS4A6A → TPK1 (>>) |
| MS4A6A → TLR4 (>>) |
| MS4A6A → TM6SF1 (>>) |
| MS4A6A → SLC31A2 (>>) |
| MS4A6A → GGTA1 (>>) |
| MS4A6A → ST14 (>>) |
| MS4A6A → ERF (>>) |
| MS4A6A → MNDA (>>) |
| MS4A6A → SLC44A2 (>>) |
| MS4A6A → FAM105A (>>) |
| MS4A6A → LXN (>>) |
| MS4A6A → TLR7 (>>) |
| MS4A6A → HGF (>>) |
| MS4A6A → CASP4 (>>) |
| MS4A6A → ATP8B4 (>>) |
| MS4A6A → NAIP (>>) |
| MS4A6A → EVI2B///EVI2A (>>) |
| MS4A6A → MAF (>>) |
| MS4A6A → RGS18 (>>) |
| MS4A6A → C3AR1 (>>) |
